REGN - Regeneron Pharmaceuticals, Inc.

Stock Analysis

Data: 2026-03-20
Last updated: Mar 22, 2026 at 2:45 PMFresh

show_chart Price & Trend 797.91 • 52W 476.49 - 807.83

Volume
Close
EMA9
MA50
MA150
MA200
Breakout
MA200 Reclaim
MA50 Touch
Pocket Pivot
PB Bounce
EMA9 Cross

auto_graph Pattern Recognition

info
info

Moderate pattern consistency: 59% win rate.

Signal Success Rate
59%
94 total signals
Avg Gain on Winners
+4.8%
55 wins
Avg Loss on Losers
-4.1%
39 losses
Recurring Behaviors
trending_up Tendency to go on win streaks (longest: 10 signals in a row)
trending_down Warning: Can experience losing streaks (longest: 6 signals)
Best Signal Type
MA50Touch
10 signals • 70% win rate
Avg gain: +1.4%
Worst Signal Type
Breakout
12 signals • 50% win rate
Avg loss: 0.3%
All Signal Types (Best ? Worst)
MA50Touch 70%
10 signals +1.4%
MA200Reclaim 67%
6 signals +1.9%
PullbackBounce 58%
19 signals +1.5%
PocketPivot 57%
47 signals +1.0%
Breakout 50%
12 signals +0.3%
Trading Insights
lightbulb Focus on MA50Touch signals - 70% win rate.

Swing Cycle Analysis

Dominant pattern: ±3% every ~2.0 days (strength 0.30)

No consistent swing rhythm detected — observed ±3% fluctuations appear irregular or noise-driven.

Swing activity (±3% over ~2.0 days) is present but weak — slight downward bias (more troughs than peaks); pattern confidence is low.

Swing Avg Days Strength Pattern?
3% 2.0 0.30 Weak+ ?
1% 0.0 0.00 Weak
2% 0.0 0.00 Weak
???????????????????????????????????????????????????????????????1201.760009765625483.0700073242187506-0408-1510-2501-0803-2406-0408-1510-2701-07
? Trough ? Peak(turning points)

No consistent swing rhythm detected — observed ±3% fluctuations appear irregular or noise-driven.

assessment Key Metrics Universe Updated

Price
$797.91
Score U
0.696
RS 6M U
94
RS 3M U
98

description Recommendation Summary

Buy Confidence: 10/10 Performance: B+ Good R/C: 0.15:1

BUY (Confidence: 10/10) - Breakout Candidate | Strong Uptrend (Stage 2) | Explosive Momentum (Elite) | R/R 0.15:1 (Risk 8.0%) | Avoid/Extended

Trend

Strong Uptrend (Stage 2)

Momentum

Explosive Momentum (Elite)

Setup Type

Breakout Candidate

grade Absolute Rating

Strong Buy Standalone Technical Quality
check_circle Trend Strength (Price > MA50, proper stack) (2 points)
check_circle 13W Return ? +20% (2 points)
check_circle 4W Return ? +8% (1 points)
check_circle Up/Down Volume ? 1.10 (1 points)
check_circle ATR(20) ? 3.5% (1 points)
cancel Within 5%-25% of 52W High (0 points)
cancel Risk/Reward ? 2:1 (R/R 0.15:1) (0 points)
Total Points: 7 out of 9
Future Analytics

Coming soon...

security Risk Management

Suggested Stop Loss

$734.07

8.0% risk
Potential Upside

+1.2%

R/R: 0.1:1
Expected Move (20 d, ATR Proxy)
±$79.02 (9.9%)
Range: $718.88 - $876.93

insights What It Means

The stock shows a mix of technical characteristics with strong relative strength and a solid composite score. Some developing risks (e.g., Stretched above MA200 +32%) to monitor. Risk/Reward moderate (~0.2:1); catalysts or consolidation may improve it.

Positives
check_circle

Strong relative strength (RS6M 94, RS3M 98)

check_circle

Absolute rating Strong Buy

check_circle

Perfect moving average stack (healthy uptrend)

check_circle

Accumulation (Up/Down Vol 1.40)

Negatives / Risks
warning

Stretched above MA200 +32%

thumb_up Bullish Factors 9

check_circle

Elite 6m RS: 94th percentile (top 6%)

check_circle

Elite 3m RS: 98th percentile (top 2%)

check_circle

Accelerating momentum (3m > 6m RS)

check_circle

Perfect MA stack (MA50 > MA150 > MA200)

check_circle

Price above all major MAs (strong trend)

check_circle

Strong accumulation: 1.40x up/down volume

check_circle

Strong 1-week gain: +3.1%

check_circle

Near 52-week high: -1.2% off peak

check_circle

Risk/Reward: 0.15:1 (Risk 8.0%, Reward 1.2% )

thumb_down Bearish Factors 1

cancel

Suboptimal R/R (<1:1)

analytics Technical Indicators

Current Price
$797.91
MA 50
$723.24
10.3%
MA 150
$613.42
30.1%
MA 200
$606.06
31.7%

News & Sentiment

Last updated Mar 22 14:45

Sentiment line (?1..+1) with scaled article volume bars (height relative to sentiment range). Rolling 7d average smooths trend.

Positive day
Negative day
Neutral
Sentiment
7d Avg
Avg 7d: +0.05 Articles 7d: 19 Latest: -0.05 (2)Peak: +0.18 Mar 15
How The Regeneron (REGN) Story Is Shifting As Dupixent And Pipeline Expectations Reset
REGN stock - BingNews Mar 22 7:17 AM 0.00
Regeneron Pharmaceuticals is back in focus after a refreshed valuation framework lifted the modelled fair value estimate from US$821.12 to US$873.78 per share, a step up that pushes implied targets ...
Assessing Regeneron Pharmaceuticals (REGN) Valuation After Recent Weak Share Momentum And Franchise Outlook - simplywall.st
"REGN stock" - Google News Mar 22 6:22 AM -0.10
Assessing Regeneron Pharmaceuticals (REGN) Valuation After Recent Weak Share Momentum And Franchise Outlook simplywall.st
Why Regeneron Pharmaceuticals (REGN) is one of the top gene therapy stocks to buy according to hedge funds - MSN
"REGN stock" - Google News Mar 21 9:31 AM 0.00
Why Regeneron Pharmaceuticals (REGN) is one of the top gene therapy stocks to buy according to hedge funds MSN
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
"REGN stock" - Google News Mar 21 6:54 AM 0.00
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) The Globe and Mail
Union Bancaire Privee UBP SA Boosts Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
"REGN stock" - Google News Mar 21 4:47 AM +0.10
Union Bancaire Privee UBP SA Boosts Stock Position in Regeneron Pharmaceuticals, Inc. $REGN MarketBeat
Is It Time To Revisit Regeneron (REGN) After Recent Share Price Pullback? - simplywall.st
"REGN stock" - Google News Mar 21 4:09 AM 0.00
Is It Time To Revisit Regeneron (REGN) After Recent Share Price Pullback? simplywall.st
BofA Securities Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $860 - Moomoo
"REGN stock" - Google News Mar 20 7:31 AM 0.00
BofA Securities Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $860 Moomoo
REGN Technical Analysis | Trend, Signals & Chart Patterns | REGENERON PHARMACEUTICALS (NASDAQ:REGN) - ChartMill
"REGN stock" - Google News Mar 20 12:00 AM 0.00
REGN Technical Analysis | Trend, Signals & Chart Patterns | REGENERON PHARMACEUTICALS (NASDAQ:REGN) ChartMill
Groupama Asset Managment Sells 5,169 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
"REGN stock" - Google News Mar 19 2:39 AM +0.10
Groupama Asset Managment Sells 5,169 Shares of Regeneron Pharmaceuticals, Inc. $REGN MarketBeat
}
Stock Scanner logo
Stock Scanner

Stock Scanner v1.0.0

Copyright Ⓒ 2025